Update in lung cancer: Prologue to a modern review series
Author:
Affiliation:
1. Asbestos Diseases Research Institute; University of Sydney; Concord New South Wales Australia
2. University of Queensland Thoracic Research Centre; The Prince Charles Hospital; Brisbane Queensland Australia
Funder
NHMRC Practitioner Fellowship
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.12457/fullpdf
Reference8 articles.
1. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N. Engl. J. Med.,2011
2. Results of the two incidence screenings in the National Lung Screening Trial;Aberle;N. Engl. J. Med.,2013
3. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N. Engl. J. Med.,2010
4. Personalized medicine in lung cancer: what we need to know;Mok;Nat. Rev. Clin. Oncol.,2011
5. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non‐small‐cell lung cancer cells through activating TGF‐β pathway and IL‐6/JAK2/STAT3 pathway;Journal of Cellular Physiology;2019-10-10
2. Effect of butein and glucose on oxidative stress and p38 activation marker in non-small cell lung cancer cell;Human & Experimental Toxicology;2019-06-19
3. HOXA4-regulated miR-138 suppresses proliferation and gefitinib resistance in non-small cell lung cancer;Molecular Genetics and Genomics;2018-09-08
4. LINK-A promotes cell proliferation through the regulation of aerobic glycolysis in non-small-cell lung cancer;OncoTargets and Therapy;2018-09
5. MicroRNA-138 Inhibits Cell Growth, Invasion, and EMT of Non-Small Cell Lung Cancer via SOX4/p53 Feedback Loop;Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics;2018-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3